Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL)-Reference-Cited by-同舟云学术

Comparison of two regimens for the treatment of elderly patients with acute lymphoblastic leukaemia (ALL)

Published:2005-01 Issue:2 Volume:46 Page:233-238
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Offidani Massimo,Corvatta Laura,Malerba Lara,Marconi Monica,Catarini Massimo,Centurioni Riccardo,Leoni Franco,Scortechini Anna Rita,Masia Maria Cristiana,Leoni Pietro

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428190400019917

Reference26 articles.

1. The biology and treatment of acute lymphoblastic leukemia in adults

2. Clinical Significance of Cytogenetic Abnormalities in Adult Acute Lymphoblastic Leukemia

3. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia

4. Leukemias, myeloma, and other lymphoreticular neoplasms

5. High-dose daunorubicin as liposomal compound (Daunoxome®) in elderly patients with acute lymphoblastic leukemia1

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of patients with acute lymphoblastic leukemia who are not suitable for high-dose chemotherapy and hematopoietic stem cell transplantation;Medical review;2022

2. How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia;Haematologica;2019-10-03

3. Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in older adults: Current treatment and novel therapies;Best Practice & Research Clinical Haematology;2017-09

4. Thiotepa-based conditioning for allogeneic stem cell transplantation in acute lymphoblastic leukemia-A survey from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation;American Journal of Hematology;2016-11-18

5. Treating adults with acute lymphocytic leukemia: new pharmacotherapy options;Expert Opinion on Pharmacotherapy;2016-10-31